suberoyl bis-hydroxamic acid has been researched along with entinostat in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, KT; Boyle, GM; Fairlie, DP; Gardiner, DL; Kahnberg, P; Le, GT; Lucke, AJ; Skinner-Adams, TS; Tran, TN | 1 |
| Bradner, JE; Grachan, ML; Greenberg, EF; Haggarty, SJ; Mazitschek, R; Warnow, T; West, N | 1 |
| Flis, S; Gnyszka, A; Spławiński, J | 1 |
| Flis, K; Flis, S; Gnyszka, A; Spławiński, J | 1 |
4 other study(ies) available for suberoyl bis-hydroxamic acid and entinostat
| Article | Year |
|---|---|
Potent antimalarial activity of histone deacetylase inhibitor analogues.
Topics: Amino Acids, Dicarboxylic; Animals; Antimalarials; Cysteine; Drug Resistance; Enzyme Inhibitors; Erythrocytes; Histone Deacetylase Inhibitors; Humans; Models, Molecular; Parasitic Sensitivity Tests; Plasmodium falciparum; Sequence Homology, Amino Acid | 2008 |
Chemical phylogenetics of histone deacetylases.
Topics: | 2010 |
HDAC inhibitors, MS275 and SBHA, enhances cytotoxicity induced by oxaliplatin in the colorectal cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Drug Synergism; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Membrane Potential, Mitochondrial; Organoplatinum Compounds; Oxaliplatin; Pyridines | 2009 |
MS275 enhances cytotoxicity induced by 5-fluorouracil in the colorectal cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Synergism; Fluorouracil; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Membrane Potential, Mitochondrial; Pyridines | 2010 |